Philippe Pouletty

1.1k total citations
37 papers, 664 citations indexed

About

Philippe Pouletty is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Philippe Pouletty has authored 37 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Philippe Pouletty's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Renal Transplantation Outcomes and Treatments (9 papers) and T-cell and B-cell Immunology (8 papers). Philippe Pouletty is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Renal Transplantation Outcomes and Treatments (9 papers) and T-cell and B-cell Immunology (8 papers). Philippe Pouletty collaborates with scholars based in United States, France and Canada. Philippe Pouletty's co-authors include Roland Buelow, Carol Clayberger, Jean Kadouche, Mercedes García‐González, Linda W. Moore, Hans Grosse‐Wilde, Jean-Louis Touraine, Régis Josien, Jean‐Paul Soulillou and M. Roy First and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Frontiers in Immunology.

In The Last Decade

Philippe Pouletty

35 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Pouletty United States 15 265 260 168 147 92 37 664
J Stuart United States 11 178 0.7× 109 0.4× 121 0.7× 64 0.4× 71 0.8× 22 458
C. B. CARPENTER United States 10 293 1.1× 410 1.6× 291 1.7× 64 0.4× 25 0.3× 10 737
Andrew L. Lobashevsky United States 17 518 2.0× 258 1.0× 416 2.5× 79 0.5× 25 0.3× 41 869
Karen Price United States 8 368 1.4× 428 1.6× 238 1.4× 94 0.6× 86 0.9× 19 817
R. M. Goldblum United States 12 111 0.4× 101 0.4× 50 0.3× 97 0.7× 58 0.6× 28 535
Marleen Seiler Germany 6 138 0.5× 116 0.4× 116 0.7× 128 0.9× 15 0.2× 6 579
B. Suárez Spain 14 53 0.2× 360 1.4× 66 0.4× 65 0.4× 55 0.6× 25 626
Yumi Nakayama Japan 16 46 0.2× 351 1.4× 63 0.4× 167 1.1× 40 0.4× 47 739
S Mahajan India 13 35 0.1× 454 1.7× 48 0.3× 163 1.1× 157 1.7× 29 761
J Peña United Kingdom 6 202 0.8× 313 1.2× 367 2.2× 54 0.4× 12 0.1× 10 779

Countries citing papers authored by Philippe Pouletty

Since Specialization
Citations

This map shows the geographic impact of Philippe Pouletty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Pouletty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Pouletty more than expected).

Fields of papers citing papers by Philippe Pouletty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Pouletty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Pouletty. The network helps show where Philippe Pouletty may publish in the future.

Co-authorship network of co-authors of Philippe Pouletty

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Pouletty. A scholar is included among the top collaborators of Philippe Pouletty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Pouletty. Philippe Pouletty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hervé, Roxane, Luca Semerano, Natacha Bessis, et al.. (2025). Intra-articular sustained-release colchicine is efficacious in an inflammatory arthritis rat model. RMD Open. 11(3). e005988–e005988.
2.
Giavina‐Bianchi, Pedro, Éric Cua, V. Mondain, et al.. (2023). ABX464 (obefazimod) for patients with COVID-19 at risk for severe disease: miR-AGE, a randomized, double-blind placebo-controlled trial. SHILAP Revista de lepidopterología. 2(4). 100140–100140. 3 indexed citations
3.
Sukavaneshvar, Sivaprasad, et al.. (2022). In-vitro Assessments of Clot Elicitation by Thrombogenic Fibers vs. Embolization Coils. ASAIO Journal. 68(10). 1256–1262. 1 indexed citations
4.
Bensussan, Armand, B Bizzini, Philippe Pouletty, Robert C. Gallo, & Daniel Zagury. (2008). Les kinoïdes. médecine/sciences. 24(3). 306–313. 4 indexed citations
5.
Pouletty, Philippe. (2003). Rapid Isotyping of Mouse Monoclonal Antibodies. Humana Press eBooks. 45. 69–78. 1 indexed citations
6.
Rossi, Stefano, et al.. (1999). Liquid medication dispensing and dose monitoring: the Cyclotech Cyclosporine Oral Solution Dispenser. Transplantation Proceedings. 31(4). 65S–66S. 2 indexed citations
7.
Schroeder, Timothy, et al.. (1998). Comparison of Two Cyclosporine Formulations in Healthy Volunteers: Bioequivalence of the New Sang‐35 Formulation and Neoral. The Journal of Clinical Pharmacology. 38(9). 807–814. 23 indexed citations
8.
Gaber, Lillian W., Linda W. Moore, A. Osama Gaber, et al.. (1998). UTILITY OF STANDARDIZED HISTOLOGICAL CLASSIFICATION IN THE MANAGEMENT OF ACUTE REJECTION1. Transplantation. 65(3). 376–380. 39 indexed citations
9.
Giral, Magali, María Cristina Cuturi, Jean‐Michel Nguyen, et al.. (1997). DECREASED CYTOTOXIC ACTIVITY OF NATURAL KILLER CELLS IN KIDNEY ALLOGRAFT RECIPIENTS TREATED WITH HUMAN HLA-DERIVED PEPTIDE. Transplantation. 63(7). 1004–1011. 20 indexed citations
10.
Campbell, Kevin, et al.. (1997). Characterization of anti-Thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA. Transplant Immunology. 5(1). 49–56. 10 indexed citations
11.
Gaber, Lillian W., Linda W. Moore, A. Osama Gaber, et al.. (1997). A multicenter report on the utilization of Banff grading in acute renal rejection. Transplantation Proceedings. 29(1-2). 184–185. 7 indexed citations
12.
Lussow, Alexander R., et al.. (1996). TARGETING OF ANTIHAPTEN ANTIBODIES TO ACTIVATED T CELLS VIA AN IL-2-HAPTEN CONJUGATE PROLONGS CARDIAC GRAFT SURVIVAL1. Transplantation. 62(12). 1703–1708. 4 indexed citations
13.
Kerman, Ronald H., Roland Buelow, Philippe Pouletty, et al.. (1996). CORRELATION OF ELISA-DETECTED IgG AND IgA ANTI-HLA ANTIBODIES IN PRETRANSPLANT SERA WITH RENAL ALLOGRAFT REJECTION1. Transplantation. 62(2). 201–205. 69 indexed citations
14.
Buelow, Roland, Frans H.J. Claas, Osama Gaber, et al.. (1995). SOLUBLE HLA ANTIGENS AND ELISA—A NEW TECHNOLOGY FOR CROSSMATCH TESTING1. Transplantation. 60(12). 1594–1599. 29 indexed citations
15.
Buelow, Roland, Isabelle Le Mercier, Frans H.J. Claas, et al.. (1995). Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Human Immunology. 44(1). 1–11. 58 indexed citations
16.
Mercier, Isabelle Le, et al.. (1994). Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay. Human Immunology. 40(3). 218–227. 11 indexed citations
17.
Grumet, F. Carl, et al.. (1994). Report of the second international soluble HLA (sHLA) workshop. Human Immunology. 40(3). 153–165. 14 indexed citations
18.
Buelow, Roland, et al.. (1994). Soluble HLa-antigens and ELISA: New technology for panel reactive antibody and crossmatch testing. Human Immunology. 40. 62–62. 5 indexed citations
19.
Pouletty, Philippe, et al.. (1993). Typing of serum‐soluble HLA‐B27 antigen by ELISA. Tissue Antigens. 42(1). 14–19. 20 indexed citations
20.
Schroeder, T J, et al.. (1993). Monitoring of OKT3(R) Serum Concentrations Using a Cartridge-Based Enzyme Immunoassay System. Therapeutic Drug Monitoring. 15(2). 151–151. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Stuart Breakdown of academic impact, for papers by C. B. CARPENTER Breakdown of academic impact, for papers by Andrew L. Lobashevsky Breakdown of academic impact, for papers by Karen Price Breakdown of academic impact, for papers by R. M. Goldblum Breakdown of academic impact, for papers by Marleen Seiler Breakdown of academic impact, for papers by B. Suárez Breakdown of academic impact, for papers by Yumi Nakayama Breakdown of academic impact, for papers by S Mahajan Breakdown of academic impact, for papers by J Peña
Rankless by CCL
2026